Zhang Xiyue
Department of Neurology, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning Province, China.
J Neurochem. 2025 Jun;169(6):e70119. doi: 10.1111/jnc.70119.
This paper aimed to disclose the correlation of high-density lipoprotein cholesterol (HDL-C)-carried microRNA-28-5p (miR-28-5p) with acute ischemic stroke (AIS). This study retrospectively included 216 first-diagnosed AIS patients (study subjects) and 102 healthy people (controls). Clinical data, serum total cholesterol (TC), triglycerides (TG), glucose, homocysteine (Hcy), HDL-C, low-DL-C (LDL-C), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), high-sensitivity C-reactive protein (hs-CRP), and fasting serum samples were collected. Serum miR-28-5p levels and disease severity were assessed by RT-qPCR and National Institutes of Health Stroke Scale (NIHSS). The diagnostic efficacy of miR-28-5p and Hcy for AIS and disease severity was evaluated using ROC curves. miR-28-5p was upregulated in AIS patients, positively correlated with HDL-C (p < 0.001, r = 0.848), and negatively correlated with TC (p < 0.001, r = 0.673). HDL-C-carried miR-28-5p was an independent influencing factor for AIS (p = 0.027, OR = 1.294, 95% CI = 1.030-1.626) and helped diagnose AIS (AUC = 0.938, 95% CI = 0.912-0.963). miR-28-5p was positively correlated with NIHSS scores (p < 0.001, r = 0.777) in AIS patients, and provided diagnostic value for AIS (positive predictive value [PPV] = 96.907%, negative predictive value [NPV] = 77.419%) and AIS severity (PPV = 95.200%, NPV = 75.824%). PPV > 95% and NPV < 90% suggested that miR-28-5p offered auxiliary diagnostic value for AIS and its severity, with limited diagnostic accuracy, and there might be a relatively high risk of missed diagnosis. The combination of miR-28-5p and Hcy improved the diagnostic value of miR-28-5p alone for AIS and its severity. Collectively, HDL-C-carried miR-28-5p is highly expressed in AIS patients and positively correlated with NIHSS score. It is an independent influencing factor for AIS and may assist in diagnosing AIS and its severity. Additionally, miR-28-5p combined with Hcy can increase the diagnostic value of miR-28-5p single detection for AIS and its severity.
本文旨在揭示高密度脂蛋白胆固醇(HDL-C)携带的微小RNA-28-5p(miR-28-5p)与急性缺血性脑卒中(AIS)之间的相关性。本研究回顾性纳入了216例首次诊断为AIS的患者(研究对象)和102名健康人(对照组)。收集了临床资料、血清总胆固醇(TC)、甘油三酯(TG)、血糖、同型半胱氨酸(Hcy)、HDL-C、低密度脂蛋白胆固醇(LDL-C)、白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)、高敏C反应蛋白(hs-CRP)以及空腹血清样本。通过逆转录定量聚合酶链反应(RT-qPCR)和美国国立卫生研究院卒中量表(NIHSS)评估血清miR-28-5p水平和疾病严重程度。使用受试者工作特征曲线(ROC曲线)评估miR-28-5p和Hcy对AIS及疾病严重程度的诊断效能。miR-28-5p在AIS患者中上调,与HDL-C呈正相关(p<0.001,r = 0.848),与TC呈负相关(p<0.001,r = 0.673)。HDL-C携带的miR-28-5p是AIS的独立影响因素(p = 0.027,OR = 1.294,95%置信区间[CI] = 1.030 - 1.626),有助于诊断AIS(曲线下面积[AUC] = 0.938,95% CI = 0.912 - 0.963)。在AIS患者中,miR-28-5p与NIHSS评分呈正相关(p<0.001,r = 0.777),并为AIS(阳性预测值[PPV] = 96.907%,阴性预测值[NPV] = 77.419%)及其严重程度(PPV = 95.200%,NPV = 75.824%)提供诊断价值。PPV>95%且NPV<90%表明miR-28-5p对AIS及其严重程度具有辅助诊断价值,但诊断准确性有限,可能存在相对较高的漏诊风险。miR-28-5p与Hcy联合使用可提高miR-28-5p单独对AIS及其严重程度的诊断价值。总体而言,HDL-C携带的miR-28-5p在AIS患者中高表达,与NIHSS评分呈正相关。它是AIS的独立影响因素,可能有助于诊断AIS及其严重程度。此外,miR-28-5p与Hcy联合使用可提高miR-28-5p单项检测对AIS及其严重程度的诊断价值。